The Effect of Etelcalcetide on Bone-tissue Properties and Calcification Propensity in End Stage Kidney Disease
Latest Information Update: 23 Nov 2023
At a glance
- Drugs Etelcalcetide (Primary)
- Indications Secondary hyperparathyroidism
- Focus Therapeutic Use
- Acronyms Parsabiv-MBD
Most Recent Events
- 01 Nov 2023 Primary endpoint has been met. (Change in Bone Mineral Density (BMD) of the Femoral Neck by Dual-energy X-ray Absorptiometry (DXA), as per Results published in the Clinical Journal of The American Society of Nephrology: CJASN
- 01 Nov 2023 Primary endpoint has been met. (Percent Change in PTH Levels), as per Results published in the Clinical Journal of The American Society of Nephrology: CJASN
- 01 Nov 2023 Results published in the Clinical Journal of The American Society of Nephrology: CJASN